Literature DB >> 17875639

Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma2 subunits.

Zhan-Heng Qi1, Maengseok Song, Melisa J Wallace, Dan Wang, Philip M Newton, Thomas McMahon, Wen-Hai Chou, Chao Zhang, Kevan M Shokat, Robert O Messing.   

Abstract

Ethanol enhances gamma-aminobutyrate (GABA) signaling in the brain, but its actions are inconsistent at GABA(A) receptors, especially at low concentrations achieved during social drinking. We postulated that the epsilon isoform of protein kinase C (PKCepsilon) regulates the ethanol sensitivity of GABA(A) receptors, as mice lacking PKCepsilon show an increased behavioral response to ethanol. Here we developed an ATP analog-sensitive PKCepsilon mutant to selectively inhibit the catalytic activity of PKCepsilon. We used this mutant and PKCepsilon(-/-) mice to determine that PKCepsilon phosphorylates gamma2 subunits at serine 327 and that reduced phosphorylation of this site enhances the actions of ethanol and benzodiazepines at alpha1beta2gamma2 receptors, which is the most abundant GABA(A) receptor subtype in the brain. Our findings indicate that PKCepsilon phosphorylation of gamma2 regulates the response of GABA(A) receptors to specific allosteric modulators, and, in particular, PKCepsilon inhibition renders these receptors sensitive to low intoxicating concentrations of ethanol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875639     DOI: 10.1074/jbc.M707233200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective Gbetagamma modulation.

Authors:  Gonzalo E Yevenes; Gustavo Moraga-Cid; Ariel Avila; Leonardo Guzmán; Maximiliano Figueroa; Robert W Peoples; Luis G Aguayo
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

2.  The Cerebellar GABAAR System as a Potential Target for Treating Alcohol Use Disorder.

Authors:  David J Rossi; Ben D Richardson
Journal:  Handb Exp Pharmacol       Date:  2018

3.  A selective G betagamma-linked intracellular mechanism for modulation of a ligand-gated ion channel by ethanol.

Authors:  Gonzalo E Yevenes; Gustavo Moraga-Cid; Robert W Peoples; Günther Schmalzing; Luis G Aguayo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

Review 4.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 5.  Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice.

Authors:  Michael Foster Olive; Philip M Newton
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

6.  PKCε phosphorylation of the sodium channel NaV1.8 increases channel function and produces mechanical hyperalgesia in mice.

Authors:  Dai-Fei Wu; Dave Chandra; Thomas McMahon; Dan Wang; Jahan Dadgar; Viktor N Kharazia; Ying-Jian Liang; Stephen G Waxman; Sulayman D Dib-Hajj; Robert O Messing
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

7.  Ethanol inhibition of recombinant NMDA receptors is not altered by coexpression of CaMKII-alpha or CaMKII-beta.

Authors:  Minfu Xu; L Judson Chandler; John J Woodward
Journal:  Alcohol       Date:  2008-06-17       Impact factor: 2.405

Review 8.  The role of GABAAR phosphorylation in the construction of inhibitory synapses and the efficacy of neuronal inhibition.

Authors:  Mansi Vithlani; Stephen J Moss
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

Review 9.  How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.

Authors:  Peter Clapp; Sanjiv V Bhave; Paula L Hoffman
Journal:  Alcohol Res Health       Date:  2008

Review 10.  New insights on neurobiological mechanisms underlying alcohol addiction.

Authors:  Changhai Cui; Antonio Noronha; Hitoshi Morikawa; Veronica A Alvarez; Garret D Stuber; Karen K Szumlinski; Thomas L Kash; Marisa Roberto; Mark V Wilcox
Journal:  Neuropharmacology       Date:  2012-11-13       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.